Legislative Day


Legislative Day 2021 – Make pharmacy’s voice heard! 
January 27, 
2021
Virtual Event


IPA’s annual Legislative Day is the cornerstone of the association’s legislative and public policy efforts. With uncertainty regarding the ability of large groups to gather at the Capitol next year, IPA will transition to virtual programming and grassroots efforts. This will include guest speakers and legislative updates on January 27 (originally scheduled Legislative Day) and a virtual grassroots push to engage legislators. Help IPA and pharmacists from across the state accomplish the goal of contacting every legislative district!
 
 
Miss the 2019 Legislative Day? Watch the recorded afternoon sessions! 
Watch Sessions | CPE information
 

Schedule

7:00-9:00 am         Coffee Hour (Optional)
Make Pharmacy’s Voice Heard – Contact your state Senator and Representative! 

9:00-9:30 am         Welcome and Keynote from DHS Director Kelly Garcia 

9:30-10:00 am         Legislative Briefing

IPA’s advocacy team will provide an overview on current pharmacy issues at the Capitol and how attendees can most effectively engage their legislators virtually.

10:00-10:30 am         Award Presentations: Legislative Champion Award
Two Legislative Champion awards will be presented this year.
 
10:30-11:30 am         Legislative Panel/Closing 
Hear from legislators firsthand on the 2021 Legislative Session and how to be an effective advocate for pharmacy. 

11:30 am-4:30 pm         Make Your Voice Heard! Contact Your state Senator and Representative (Continued!)


 

Insight to Advocacy Webinar Series 

In addition to virtual Legislative Day content, IPA will also be providing engaging content from policymakers throughout the legislative session on a variety of topics. These webinars are accredited for Pharmacy Law CE. Register for individual webinars or all six!  Fees apply for some membership levels.
 

February 19: Rutledge v. PCMA – Impact on State Legislation  

In October, the Supreme Court heard oral arguments in a case that could fundamentally alter the PBM landscape among the states. Hear from experts on how exactly the SCOTUS decision could impact state’s ability to regulate PBMs. 
Speaker: John Vinson, PharmD, CEO, Arkansas Pharmacists Association (Invited)



March 5: First Funnel Update – What bills are still alive? 

Iowa’s “funnel” process means many bills are considered dead for the remainder of session. IPA’s Casey Ficek will provide an update on what pharmacy priorities are still alive and what bills failed to advance for the year.Speakers: Casey Ficek, JD, Vice President of Public Affairs, IPA; Lobbyists Kate Walton and Matt Eide



April 15: Practice Act Task Force Update

IPA and the Board of Pharmacy have begun the process of working to adopt a new Iowa Pharmacy Practice Act. Members of the task force will provide an update on what work has been done so far and what else is needed in 2021. 
Speakers: Andrew Funk, Executive Director, Iowa BOP; Members of Iowa Pharmacy Practice Act Task Force



May 14:
340B – Updates and Advocacy

Recent efforts from manufacturers to place limitations on the 340B Drug Pricing Program have resulted in renewed intensity and action from advocates to protect the 340B program. Hear from experts to learn what efforts are underway at the state and federal level to ensure this critical program remains protected. 
Speakers: TBD



June 18: Action Across the States – State Pharmacy Legislation

The National Alliance of State Pharmacy Association (NASPA) will provide an update on emerging trends for pharmacy in other state legislatures.
Speaker: Joni Cover, JD, Vice President of Strategic Initiatives, NASPA (Invited)


 

July TBD: Updates from Congress – Hear from a member of Iowa’s Congressional Delegation

Congress is considering several consequential legislative proposals impacting pharmacy. A member of Iowa’s Congressional Delegation and their staff will provide an update from Capitol Hill.  
Speakers: Casey Ficek, JD, Vice President of Public Affairs, IPA; Rep. Cindy Axne; Members of APhA Advocacy Team (Invited)